Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Carbamazepine

EU orphan designation number: EU/3/16/1746   
Active ingredient: Carbamazepine
Indication: Treatment of metaphyseal chondrodysplasia, Schmid type
Sponsor: University of Newcastle upon Tyne
Kings Gate, Newcastle upon Tyne, NE1 7RU, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/148/16 (2016)6737 of 14/10/2016